LC- and CZE-ICP-MS approaches for the in vivo analysis of the anticancer drug candidate sodium trans-[tetrachloridobis(1H-indazole)ruthenate(III)] (KP1339) in mouse plasma

Author(s)
Anna Bytzek, Katharina Böck, Gerrit Hermann, Stephan Hann, Bernhard Keppler, Christian Hartinger, Gunda Köllensperger
Abstract

Ruthenium-indazole complexes are promising anticancer agents undergoing clinical trials. KP1339 is administered intravenously (i.v.), where serum proteins are the first available biological binding partners. In order to gain a better insight into the mode of action, mice were treated with different doses of KP1339 i.v. and sacrificed at different time points. The blood plasma was isolated from blood samples and analyzed by capillary zone electrophoresis (CZE) and size exclusion/anion exchange chromatography (SEC-IC) both combined on-line to inductively coupled plasma-mass spectrometry (ICP-MS). The performance of the analytical methodology was compared and the interaction of KP1339 with mouse plasma proteins characterized in vivo. Interestingly, the samples of the mice treated with 50 mg kg(-1) and terminated after 24 h showed a ca. 4-fold lowered albumin content and increased ruthenation of albumin aggregates as compared to the untreated control group and the 40 mg kg(-1) group. The majority of Ru was bound to albumin and the stoichiometry of the KP1339 protein binding was determined through the molar Ru/S ratio. In general, good agreement of the data obtained with both techniques was achieved and the SEC-IC method was found to be more sensitive as compared to the CZE-ICP-MS approach, whereas the latter benefits from the shorter analysis time and lower sample consumption.

Organisation(s)
Department of Inorganic Chemistry
External organisation(s)
University of Natural Resources and Life Sciences
Journal
Metallomics: integrated biometal science
Volume
3
Pages
1049-1055
No. of pages
7
ISSN
1756-5901
DOI
https://doi.org/10.1039/c1mt00055a
Publication date
2011
Peer reviewed
Yes
Austrian Fields of Science 2012
301207 Pharmaceutical chemistry, 104002 Analytical chemistry
Portal url
https://ucrisportal.univie.ac.at/en/publications/e7167371-6e8c-4e5f-b677-6ed9efc606c2